相似文献
1
Reply - Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
Tremor Other Hyperkinet Mov (N Y). 2020 Dec 28;10:59. doi: 10.5334/tohm.591.
2
Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
Tremor Other Hyperkinet Mov (N Y). 2020 Dec 16;10:57. doi: 10.5334/tohm.587.
3
Classification and treatment of tardive syndromes.
Neurologist. 2003 Jan;9(1):16-27. doi: 10.1097/01.nrl.0000038585.58012.97.
4
Antipsychotic drug-induced movement disorders.
Can J Neurol Sci. 2003 Mar;30 Suppl 1:S101-7. doi: 10.1017/s0317167100003309.
5
Tardive syndromes.
J Neurol Sci. 2018 Jun 15;389:35-42. doi: 10.1016/j.jns.2018.02.005. Epub 2018 Feb 5.
6
Drug-induced movement disorders.
Neurol Clin. 2015 Feb;33(1):153-74. doi: 10.1016/j.ncl.2014.09.011.
7
Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence.
J Clin Psychiatry. 1995 Oct;56(10):476-83.
8
[Drug-induced movement disorders: tardive syndromes].
Therapie. 2004 Jan-Feb;59(1):113-9. doi: 10.2515/therapie:2004022.
9
Acute and subacute drug-induced movement disorders.
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S108-12. doi: 10.1016/S1353-8020(13)70027-0.
10
Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
Headache. 2016 Jan;56(1):153-61. doi: 10.1111/head.12712. Epub 2015 Nov 17.
本文引用的文献
1
Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
Tremor Other Hyperkinet Mov (N Y). 2020 Oct 26;10:48. doi: 10.5334/tohm.554.
2
A case of dyskinesia after levetiracetam administration.
BMC Neurol. 2019 Nov 18;19(1):292. doi: 10.1186/s12883-019-1519-8.
3
Insights into Pathophysiology from Medication-induced Tremor.
Tremor Other Hyperkinet Mov (N Y). 2017 Nov 22;7:442. doi: 10.7916/D8FJ2V9Q. eCollection 2017.
Zotero 插件